...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Analysis of very important pharmacogene variants in the Tibetan population from China
【24h】

Analysis of very important pharmacogene variants in the Tibetan population from China

机译:中国藏族人口中非常重要的药物转基因分析

获取原文
获取原文并翻译 | 示例
           

摘要

Personalized medicine, the treatment best suited for an individual, is a hot field of clinical research in the world. Many recent studies have shown that genetic variations have a great influence on the treatment. This study aimed to identify the distribution differences of very important pharmacogene (VIP) variants between the Tibetan population and the other 26 populations from the 1000 Genomes project. Based on the PharmGKB database, we successfully genotyped 50 VIP variants located in 27 genes in the Tibetan population. We also compared the genotype frequencies of VIP variants between Tibetan population and the other 26 populations. Without adjustment, the Chi-square test showed that the only significant variant between Tibetans and every other group was rs1801159 in dihydropyrimidine dehydrogenase (DPYD), followed by rs1800566 in NAD(P)H quinone dehydrogenase 1 (NQO1) and rs1051296 in solute carrier family 19 member 1 (SLC19A1). After Bonferroni's multiple adjustments, the genotype frequencies distribution of DPYD rs1801159 was found to be different in Tibetans compared to the other 26 groups, apart from ACB and ASW. Moreover, genetic structure/F-statistics (Fst) analysis and the phylogenetic tree illustrated that Tibetans had a closer affinity with CDX, CHB, CHS, JPT and KHV. Our data will complement pharmacogenomics information of the Tibetan population and provide theoretical support for the realization of individualized medical treatment for Tibetans in the future.
机译:None

著录项

  • 来源
  • 作者单位

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Affiliated Hosp Xianyang Peoples R China;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

    Xizang Minzu Univ Affiliated Hosp Xianyang Peoples R China;

    Xizang Minzu Univ Affiliated Hosp Xianyang Peoples R China;

    Xizang Minzu Univ Sch Med Key Lab Mol Mech &

    Intervent Res Plateau Dis Tibe 6 Wenhui Rd;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

    dihydropyrimidine dehydrogenase; genetic polymorphism; Tibetan; VIP variants;

    机译:二氢嘧啶脱氢酶;遗传多态性;藏族;VIP变体;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号